Rayence Co. Ltd (228850) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Rayence Co. Ltd (228850) has a cash flow conversion efficiency ratio of 0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.22 Billion ≈ $1.50 Million USD) by net assets (₩242.10 Billion ≈ $164.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 228850 market cap overview for the company's overall valuation and market capitalisation.
Rayence Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Rayence Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Rayence Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rayence Co. Ltd ranked by their cash flow conversion efficiency. Explore Rayence Co. Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Polaris Office Corp
KQ:041020
|
0.010x |
|
Ares International Corp
TW:2471
|
0.142x |
|
Da Ming International Holdings Limited
F:DM7
|
-0.098x |
|
Railcare Group AB (publ)
ST:RAIL
|
0.232x |
|
Hyundai Livart Furniture Co Ltd
KO:079430
|
-0.004x |
|
Super Dragon Technology Co Ltd
TW:9955
|
0.036x |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
0.004x |
|
PolyPid
NASDAQ:PYPD
|
-2.876x |
Annual Cash Flow Conversion Efficiency for Rayence Co. Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Rayence Co. Ltd from 2015 to 2025. View current stock price of Rayence Co. Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩237.37 Billion ≈ $160.86 Million |
₩9.21 Billion ≈ $6.24 Million |
0.039x | -61.79% |
| 2024-12-31 | ₩244.67 Billion ≈ $165.81 Million |
₩24.84 Billion ≈ $16.83 Million |
0.102x | -5.32% |
| 2023-12-31 | ₩240.80 Billion ≈ $163.19 Million |
₩25.82 Billion ≈ $17.50 Million |
0.107x | +45.11% |
| 2022-12-31 | ₩224.75 Billion ≈ $152.31 Million |
₩16.61 Billion ≈ $11.25 Million |
0.074x | -29.22% |
| 2021-12-31 | ₩200.58 Billion ≈ $135.93 Million |
₩20.94 Billion ≈ $14.19 Million |
0.104x | -15.53% |
| 2020-12-31 | ₩188.17 Billion ≈ $127.52 Million |
₩23.25 Billion ≈ $15.76 Million |
0.124x | +154.02% |
| 2019-12-31 | ₩194.30 Billion ≈ $131.67 Million |
₩9.45 Billion ≈ $6.41 Million |
0.049x | -39.82% |
| 2018-12-31 | ₩181.86 Billion ≈ $123.25 Million |
₩14.70 Billion ≈ $9.96 Million |
0.081x | -30.74% |
| 2017-12-31 | ₩176.64 Billion ≈ $119.71 Million |
₩20.62 Billion ≈ $13.97 Million |
0.117x | +130.75% |
| 2016-12-31 | ₩165.42 Billion ≈ $112.10 Million |
₩8.37 Billion ≈ $5.67 Million |
0.051x | -67.47% |
| 2015-12-31 | ₩60.02 Billion ≈ $40.67 Million |
₩9.33 Billion ≈ $6.32 Million |
0.155x | -- |
About Rayence Co. Ltd
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more